Roche

[video] Drugs IPOs Depend on Deals

[video] Drugs IPOs Depend on Deals

TheStreet.com

Roche's Tarceva Progresses in Japan

Roche's Tarceva Progresses in Japan

Yahoo/Zacks

PDL BioPharma wants arbitration in royalty dispute

PDL BioPharma wants arbitration in royalty dispute

Yahoo/AP

Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?

Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?

Seeking Alpha

Roche's Avastin fails to prolong survival in brain cancer study

Roche's Avastin fails to prolong survival in brain cancer study

Reuters

New Approvals Spark a Melanoma Drug Battle

New Approvals Spark a Melanoma Drug Battle

Motley Fool

Erbitux Tops Roche’s Avastin for Colon Cancer Survival

Erbitux Tops Roche’s Avastin for Colon Cancer Survival

Bloomberg

Cancer Immunotherapy the Top Focus at ASCO

Cancer Immunotherapy the Top Focus at ASCO

CNBC

Roche, Reloaded

Roche, Reloaded

Investopedia

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail

Bloomberg